Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.
Diabetes Care. 2000 Dec;23(12):1816-22. doi: 10.2337/diacare.23.12.1816.
Diabetes Care. 2000.
PMID: 11128359
Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients.
Buysschaert M, Jamart J, Dramais AS, Wallemacq P, Hermans MP.
Buysschaert M, et al. Among authors: dramais as.
Diabetes Metab. 2001 Dec;27(6):655-9.
Diabetes Metab. 2001.
PMID: 11852373
Item in Clipboard
ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients.
Buysschaert M, D'Hooge D, Preumont V; Roots Study Group.
Buysschaert M, et al.
Diabetes Metab Syndr. 2015 Jul-Sep;9(3):139-42. doi: 10.1016/j.dsx.2015.05.001. Epub 2015 May 8.
Diabetes Metab Syndr. 2015.
PMID: 26004030
Item in Clipboard
One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice.
Buysschaert M, Preumont V, Oriot PR, Paris I, Ponchon M, Scarnière D, Selvais P; UCL Study Group for Exenatide.
Buysschaert M, et al.
Diabetes Metab. 2010 Nov;36(5):381-8. doi: 10.1016/j.diabet.2010.03.009. Epub 2010 Jul 2.
Diabetes Metab. 2010.
PMID: 20598606
Item in Clipboard
Cite
Cite